1. Home
  2. CATO vs GANX Comparison

CATO vs GANX Comparison

Compare CATO & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

SELL

Current Price

$2.31

Market Cap

46.0M

ML Signal

SELL

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$0.95

Market Cap

52.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CATO
GANX
Founded
1946
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
52.2M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CATO
GANX
Price
$2.31
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $7.20
AVG Volume (30 Days)
37.3K
★ 550.3K
Earning Date
11-19-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 68.04
31.46
EPS
★ 0.53
N/A
Revenue
★ $653,812,000.00
$55,180.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.47
★ N/A
Revenue Growth
★ 0.62
N/A
52 Week Low
$2.28
$1.10
52 Week High
$3.87
$4.34

Technical Indicators

Market Signals
Indicator
CATO
GANX
Relative Strength Index (RSI) 48.05 29.09
Support Level $2.29 N/A
Resistance Level $2.48 $2.01
Average True Range (ATR) 0.05 0.10
MACD 0.01 0.00
Stochastic Oscillator 69.21 3.61

Price Performance

Historical Comparison
CATO
GANX

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

Share on Social Networks: